Literature DB >> 15448889

Blood flow reductions during continuous renal replacement therapy and circuit life.

Ian Baldwin1, Rinaldo Bellomo, Bill Koch.   

Abstract

OBJECTIVE: Reductions in blood flow rate may occur undetected during peristaltic pumping of blood through continuous renal replacement therapy circuits. We investigated whether undetected reductions in blood flow rate occur during continuous veno-venous haemofiltration, and whether they are correlated with filter life. PATIENTS: Twelve patients receiving continuous veno-venous haemofiltration in the intensive care unit of a tertiary hospital.
METHODS: Extracorporeal circuit blood flow during haemofiltration was continuously monitored utilizing a miniature ultrasound Doppler device. Otherwise undetected blood flow reductions were identified at severity levels of between 20% and 100% less than the set diastolic flow rate (83 ml/min). Information on anticoagulation status was simultaneously obtained. The frequency and severity of blood flow reductions were recorded, and the correlation with filter life was determined. MEASUREMENTS AND
RESULTS: The duration of filter life ranged from 1.5 to 53 h, with a mean functional life of 19.62+/-16.32 h. There were 314 episodes of blood flow reduction during the 525 h of monitoring (0.59 episodes/h). There was a significant inverse relationship between the number of medium-level blood flow reductions and filter life. This correlation was much stronger than that between APTT and filter life.
CONCLUSIONS: Undetected blood flow reductions occur during continuous veno-venous haemofiltration. Such reductions are frequent, and when sufficiently severe appear to be correlated with filter life more strongly than the blood coagulation variables typically used to monitor adequacy of anticoagulation and promote filter longevity.

Entities:  

Mesh:

Year:  2004        PMID: 15448889     DOI: 10.1007/s00134-004-2440-0

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  13 in total

1.  Differences between blood flow as indicated by the hemodialysis blood roller pump and blood flow measured by an ultrasonic sensor.

Authors:  J L Teruel; M Fernández Lucas; R Marcén; J R Rodríguez; J López Sánchez; M Rivera; F Liaño; J Ortuño
Journal:  Nephron       Date:  2000-06       Impact factor: 2.847

Review 2.  The Acute Dialysis Quality Initiative--part VI: access and anticoagulation in CRRT.

Authors:  Andrew Davenport; Sangeeta Mehta
Journal:  Adv Ren Replace Ther       Date:  2002-10

3.  Pressure effects on roller pump blood flow during hemodialysis.

Authors:  T A Depner; S Rizwan; T A Stasi
Journal:  ASAIO Trans       Date:  1990 Jul-Sep

4.  Setting roller pump occlusion with the transonic HT109 flowmeter.

Authors:  E J Snyder; H M Harb; J A Cullen; D L McElwee
Journal:  ASAIO J       Date:  1997 Jan-Feb       Impact factor: 2.872

5.  Low-dose heparinization for anticoagulation in intensive care patients on continuous hemofiltration.

Authors:  N Gretz; M Quintel; M Ragaller; W Odenwälder; H J Bender; P Rohmeiss; M Strauch
Journal:  Contrib Nephrol       Date:  1995       Impact factor: 1.580

6.  Simplified citrate anticoagulation for continuous renal replacement therapy.

Authors:  A J Tolwani; R C Campbell; M B Schenk; M Allon; D G Warnock
Journal:  Kidney Int       Date:  2001-07       Impact factor: 10.612

7.  Difference between delivered and prescribed blood flow in hemodialysis.

Authors:  J Sands; D Glidden; W Jacavage; B Jones
Journal:  ASAIO J       Date:  1996 Sep-Oct       Impact factor: 2.872

8.  Anticoagulation in patients treated by continuous venovenous hemofiltration: a retrospective study.

Authors:  P Y Martin; J C Chevrolet; P Suter; H Favre
Journal:  Am J Kidney Dis       Date:  1994-11       Impact factor: 8.860

9.  Anticoagulation with prostacyclin and heparin during continuous venovenous hemofiltration.

Authors:  S A Langenecker; M Felfernig; A Werba; C M Mueller; A Chiari; M Zimpfer
Journal:  Crit Care Med       Date:  1994-11       Impact factor: 7.598

10.  Use of sodium citrate anticoagulation in a pediatric continuous venovenous hemodialysis patient.

Authors:  D Macdonald; R Martin
Journal:  ANNA J       Date:  1995-06
View more
  16 in total

Review 1.  Year in review in intensive care medicine, 2004. II. Brain injury, hemodynamic monitoring and treatment, pulmonary embolism, gastrointestinal tract, and renal failure.

Authors:  Peter Andrews; Elie Azoulay; Massimo Antonelli; Laurent Brochard; Christian Brun-Buisson; Geoffrey Dobb; Jean-Yves Fagon; Herwig Gerlach; Johan Groeneveld; Jordi Mancebo; Philipp Metnitz; Stefano Nava; Jerome Pugin; Michael Pinsky; Peter Radermacher; Christian Richard; Robert Tasker; Benoit Vallet
Journal:  Intensive Care Med       Date:  2005-01-28       Impact factor: 17.440

Review 2.  Anticoagulation strategies in continuous renal replacement therapy: can the choice be evidence based?

Authors:  H M Oudemans-van Straaten; J P J Wester; A C J M de Pont; M R C Schetz
Journal:  Intensive Care Med       Date:  2006-02-02       Impact factor: 17.440

3.  Cooling and reduced risk of clotting within the extracorporeal continuous renal replacement circuit.

Authors:  Sean M Bagshaw; Andrew Davenport
Journal:  Intensive Care Med       Date:  2008-10-08       Impact factor: 17.440

4.  Building and validation of a prognostic model for predicting extracorporeal circuit clotting in patients with continuous renal replacement therapy.

Authors:  Xia Fu; Xinling Liang; Li Song; Huigen Huang; Jing Wang; Yuanhan Chen; Li Zhang; Zilin Quan; Wei Shi
Journal:  Int Urol Nephrol       Date:  2014-03-18       Impact factor: 2.370

5.  Amino Acid Loss during Continuous Venovenous Hemofiltration in Critically Ill Patients.

Authors:  Sandra N Stapel; Ruben J de Boer; Patrick J Thoral; Marc G Vervloet; Armand R J Girbes; Heleen M Oudemans-van Straaten
Journal:  Blood Purif       Date:  2019-07-10       Impact factor: 2.614

6.  Membrane pressures predict clotting of pediatric continuous renal replacement therapy circuits.

Authors:  Aadil Kakajiwala; Thomas Jemielita; John Z Hughes; Kimberly Windt; Michelle Denburg; Stuart L Goldstein; Benjamin Laskin
Journal:  Pediatr Nephrol       Date:  2017-03-01       Impact factor: 3.714

Review 7.  Non-pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy.

Authors:  Yasushi Tsujimoto; Sho Miki; Hiroki Shimada; Hiraku Tsujimoto; Hideto Yasuda; Yuki Kataoka; Tomoko Fujii
Journal:  Cochrane Database Syst Rev       Date:  2021-09-14

8.  Antithrombin level and circuit thrombosis during hemofiltration after cardiopulmonary bypass.

Authors:  H Lanquetot; T Leprince; S Ragot; C Boinot; C Jayle; R Robert; L Macchi
Journal:  Intensive Care Med       Date:  2008-06-25       Impact factor: 17.440

9.  Calculating evidence-based renal replacement therapy - Introducing an excel-based calculator to improve prescribing and delivery in renal replacement therapy - A before and after study.

Authors:  Daniel Cottle; Stephen Mousdale; Haroon Waqar-Uddin; Redmond Tully; Benjamin Taylor
Journal:  J Intensive Care Soc       Date:  2015-09-21

10.  Circuit life span in critically ill children on continuous renal replacement treatment: a prospective observational evaluation study.

Authors:  Jimena del Castillo; Jesús López-Herce; Elena Cidoncha; Javier Urbano; Santiago Mencía; Maria J Santiago; Jose M Bellón
Journal:  Crit Care       Date:  2008-07-25       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.